A review on newly approved PARP inhibitors: Talazoparib and Olaparib
This project report is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2024.
| Κύριος συγγραφέας: | |
|---|---|
| Άλλοι συγγραφείς: | |
| Μορφή: | Project report |
| Γλώσσα: | English |
| Έκδοση: |
Brac University
2024
|
| Θέματα: | |
| Διαθέσιμο Online: | http://hdl.handle.net/10361/24372 |